These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2542177)

  • 1. Processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1 in the presence of trimming glucosidase inhibitor deoxynojirimycin.
    Pal R; Kalyanaraman VS; Hoke GM; Sarngadharan MG
    Intervirology; 1989; 30(1):27-35. PubMed ID: 2542177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.
    Pal R; Hoke GM; Sarngadharan MG
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3384-8. PubMed ID: 2541446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique human immunodeficiency virus culture secreting soluble gp160.
    Kalyanaraman VS; Pal R; Gallo RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1988 Oct; 4(5):319-29. PubMed ID: 3264172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of novel 1-deoxynojirimycin derivatives on HIV-1 replication.
    Shimizu H; Tsuchie H; Yoshida K; Morikawa S; Tsuruoka T; Yamamoto H; Ushijima H; Kitamura T
    AIDS; 1990 Oct; 4(10):975-9. PubMed ID: 2148090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein.
    Fenouillet E; Gluckman JC
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1919-26. PubMed ID: 1678778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase.
    Gruters RA; Neefjes JJ; Tersmette M; de Goede RE; Tulp A; Huisman HG; Miedema F; Ploegh HL
    Nature; 1987 Nov 5-11; 330(6143):74-7. PubMed ID: 2959866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.
    Fenouillet E; Clerget-Raslain B; Gluckman JC; Guétard D; Montagnier L; Bahraoui E
    J Exp Med; 1989 Mar; 169(3):807-22. PubMed ID: 2538547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport.
    Dewar RL; Vasudevachari MB; Natarajan V; Salzman NP
    J Virol; 1989 Jun; 63(6):2452-6. PubMed ID: 2542563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-0-butanoylcastanospermine (MDL 28,574) inhibits glycoprotein processing and the growth of HIVs.
    Taylor DL; Sunkara PS; Liu PS; Kang MS; Bowlin TL; Tyms AS
    AIDS; 1991 Jun; 5(6):693-8. PubMed ID: 1652979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfation of the human immunodeficiency virus envelope glycoprotein.
    Bernstein HB; Compans RW
    J Virol; 1992 Dec; 66(12):6953-9. PubMed ID: 1433500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.
    Willey RL; Bonifacino JS; Potts BJ; Martin MA; Klausner RD
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9580-4. PubMed ID: 2849111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brefeldin A inhibits the processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1.
    Pal R; Mumbauer S; Hoke GM; Takatsuki A; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1991 Aug; 7(8):707-12. PubMed ID: 1718346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.
    Kalyanaraman VS; Rodriguez V; Veronese F; Rahman R; Lusso P; DeVico AL; Copeland T; Oroszlan S; Gallo RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):371-80. PubMed ID: 2187500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure.
    Fischer PB; Karlsson GB; Dwek RA; Platt FM
    J Virol; 1996 Oct; 70(10):7153-60. PubMed ID: 8794362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant HIV envelope expressed in an alpha-glucosidase I-deficient CHO cell line and its parental cell line in the presence of 1-deoxynojirimycin is functional.
    Fenouillet E; Papandréou MJ; Jones IM
    Virology; 1997 Apr; 231(1):89-95. PubMed ID: 9143306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alpha-glucosidase inhibitor 1-deoxynojirimycin blocks human immunodeficiency virus envelope glycoprotein-mediated membrane fusion at the CXCR4 binding step.
    Papandréou MJ; Barbouche R; Guieu R; Kieny MP; Fenouillet E
    Mol Pharmacol; 2002 Jan; 61(1):186-93. PubMed ID: 11752220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160.
    Berman PW; Riddle L; Nakamura G; Haffar OK; Nunes WM; Skehel P; Byrn R; Groopman J; Matthews T; Gregory T
    J Virol; 1989 Aug; 63(8):3489-98. PubMed ID: 2545918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus.
    Dewar RL; Natarajan V; Vasudevachari MB; Salzman NP
    J Virol; 1989 Jan; 63(1):129-36. PubMed ID: 2535720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gp160 of HIV-I synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing.
    Merkle RK; Helland DE; Welles JL; Shilatifard A; Haseltine WA; Cummings RD
    Arch Biochem Biophys; 1991 Oct; 290(1):248-57. PubMed ID: 1898096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.